Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 21, 2024Nature CommunicationsOpen Access

Immunization with V987H-stabilized Spike glycoprotein protects K18-hACE2 mice and golden Syrian hamsters upon SARS-CoV-2 infection

View Full Paper
Ask AI
Bookmark
Share

Authors

CÁCarlos Ávila‐NietoJVJúlia Vergara‐AlertPAPep Amengual-Rigo

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ávila‐Nieto et al. (2024) studied this question.

synapsesocial.com/papers/68e7309eb6db6435876aa4c0https://doi.org/10.1038/s41467-024-46714-w
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A single dose of recombinant VSV-∆G-spike vaccine provides protection against SARS-CoV-2 challenge2020 · 233 citations
  2. 2SARS‐CoV‐2 Spike Stem Protein Nanoparticles Elicited Broad ADCC and Robust Neutralization against Variants in Mice2022 · 17 citations
  3. 3A six-proline stabilized trimeric spike DNA vaccine induces robust immunity and protects against SARS-CoV-2 delta challenge in K18-hACE2 transgenic mice2026
  4. 4Immunogenicity and efficacy of homologous and heterologous NDV and MVA SARS-CoV-2 vaccines in mice and hamsters2025
  5. 5Single MVA-SARS-2-ST/N Vaccination Rapidly Protects K18-hACE2 Mice against a Lethal SARS-CoV-2 Challenge Infection2024 · 4 citations